Related Experiment Video
Updated: Jun 9, 2025

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
[Arterial hypertension-Current recommendations for action]
Milen Babic1, Oliver Vonend2, Markus van der Giet3
1Klinik für Nephrologie und internistische Intensivmedizin, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Deutschland. milen.babic@charite.de.
Insights
Arterial hypertension (aHT) affects many, with suboptimal treatment risking severe events. This article summarizes new German and European guidelines for better hypertension management and prevention of organ damage.
Area of Science:
- Cardiology
- Nephrology
- Public Health
Context:
- Arterial hypertension (aHT) prevalence is high and increasing in Germany, affecting nearly one in three individuals.
- Only 50% of treated patients achieve controlled blood pressure, increasing risks of cardiovascular and renal events.
- Suboptimal hypertension management can lead to fatal outcomes.
Purpose:
- To provide a practical summary of the current diagnostics and treatment recommendations from both the German national treatment guidelines (NVL) and the European Society of Hypertension (ESH) 2023.
- To discuss relevant differences between the two guideline updates.
- To offer routinely applicable advice for healthcare professionals.
Summary:
- Both new guidelines emphasize avoiding hypertension-mediated organ damage (HMOD) and identifying high blood pressure.
- Preventive measures, lifestyle recommendations, and simplified target blood pressure values are highlighted for routine practice.
- The article offers a comparative overview of diagnostic and therapeutic strategies.
Impact:
- Aims to improve the routine management of arterial hypertension by integrating new guideline recommendations.
- Facilitates better identification and prevention of hypertension-related complications, including organ damage.
- Supports healthcare providers in making informed decisions for patient care and treatment optimization.
Abstract:
Arterial hypertension (aHT) currently affects nearly 1 in every 3 persons in Germany and the number of those affected is steadily increasing. Only half of the patients treated show a controlled blood pressure in the follow-up. A suboptimal treatment involves the danger of cardiovascular and renal events that under certain circumstances can have a fatal course. The publication of the first national treatment guidelines (NVL) on hypertension and the new guidelines of the European Society of Hypertension (ESH) 2023 simultaneously represent two updates. Both emphasize the necessity to avoid hypertension-mediated organ damage (HMOD) and the identification of high blood pressure. The focussing on preventive measures and lifestyle recommendations as well as the simplification of target blood pressure values play important roles in the routine practice. This article provides a practical summary of the current recommendations of both guidelines on the diagnostics and treatment of aNT, discusses relevant differences and provides routinely applicable advice.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Coronary Artery Disease IV: Medical Management
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Pre-Procedural Guidelines for Assessing Blood Pressure

